Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+60.9%
5Y CAGR+76.5%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+60.9%/yr
vs +88.6%/yr prior
5Y CAGR
+76.5%/yr
Recent deceleration
Acceleration
-27.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
17.1x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $13.71M | +10.6% |
| 2024 | $12.39M | +23.0% |
| 2023 | $10.07M | +206.3% |
| 2022 | $3.29M | +1165.0% |
| 2021 | $260000.00 | -67.5% |
| 2020 | $801000.00 | -76.1% |
| 2019 | $3.35M | +1189.6% |
| 2018 | $260000.00 | +6600.0% |
| 2017 | $-4000.00 | - |